Developer docs
API playgroundTry for free, no card

Search company profiles

Glemser

Full company profile

uuid000h2gu

Namestring
Glemser
Legal namestring
Glemser, LLC
Websiteurl
glemser.com
Company typeenum
Private
Founded yearint
1987
Descriptiontext

Glemser is a privately held U.S.-based software and advisory firm founded in 1987 by Dr. Ray Glemser and headquartered in Bethlehem, Pennsylvania, with regional operations in Ireland (EMEA) and India. The company sells ComplianceAuthor AI, a cloud-based, GxP-compliant structured content authoring platform that helps pharmaceutical and life sciences teams author, manage, and publish regulatory content (labels, SmPC, USPI, SPL, FHIR ePI, QRD, PQ/CMC documentation) using a Microsoft Word front-end and component-based content management. The platform is pre-trained on life sciences content, supports CFR Part 11 and EU Annex 11 compliance, and integrates natively with Veeva Vault RIM, SAP, SharePoint, Oracle, and Documentum.

Glemser's go-to-market combines enterprise SaaS subscriptions for ComplianceAuthor AI with several services lines that often serve as entry points: on-demand label conversion services (SPL, HL7 FHIR, PharmaLedger) with 1-2 business day turnaround, Intelex EHSQ implementation and validation, and digital transformation consulting for AI/RPA initiatives in GxP environments. The company uses an enterprise field sales motion targeting large pharmaceutical and life sciences companies, supplemented by thought leadership (DIA Global Forum, Life Sciences Review Magazine), case studies, and an ROI calculator.

The firm serves a blue-chip customer base including GSK, Pfizer, Johnson & Johnson/Janssen, Gilead Sciences, Boehringer Ingelheim, AbbVie, Takeda, Incyte, BD, Thermo Fisher, and DHL, with strategic technology partnerships spanning Quark (XML publishing), Arria (NLG), Docxonomy (intelligent search), Intelex (EHSQ), and Navitas Life Sciences (CRO services). Recognized as a 'Top Regulatory Services Company – 2024' by Life Sciences Review Magazine, Glemser positions itself as a domain-specialized alternative to horizontal content and quality management vendors for the regulated life sciences market.

Short descriptiontext

Glemser is a 37-year-old private software and advisory firm that sells ComplianceAuthor AI, a GxP-compliant structured content platform, alongside label conversion, Intelex EHSQ implementation, and digital transformation services primarily to large pharmaceutical and life sciences enterprises.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBethlehem, United States
HQ citystring
Bethlehem
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical regulatory software, structured content authoring, label conversion services, life sciences compliance, regulatory content management
Industry4 codes
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHDAEANAE
Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code2 codes
  • Software Publishers51321
  • Computer Systems Design and Related Services5415
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Pharmaceutical Regulatory Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1ComplianceAuthor AI SaaS Platform
TypeSubscription Recurring
Description

Cloud-based subscription access to the ComplianceAuthor AI structured content authoring platform, providing AI-powered authoring, management, and output generation for regulatory content. Sold as an enterprise license with per-seat or organizational-tier pricing.

glemser.com
2Label Conversion Services On Demand
TypeTransaction Fee
Description

Outsourced conversion services for SPL, HL7 FHIR ePI, and PharmaLedger label formats. Customers submit files via a secure portal and receive validated, submission-ready outputs in 1-2 business days. Revenue is generated per conversion or as an ongoing service engagement.

glemser.com
3Intelex Implementation & Consulting
TypeProfessional Services
Description

Professional services for implementing and validating Intelex Environment, Health, Safety, and Quality (EHSQ) software within regulated industries. Includes project management, configuration, validation to GAMP 5 standard, and ongoing support.

glemser.com
4Digital Transformation Services
TypeProfessional Services
Description

Consulting and professional services for AI, RPA, and advanced technology implementations in life sciences, including Computer System Validation (CSV) for GxP and SOX-regulated solutions.

glemser.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1ComplianceAuthor AI
Description

AI-powered structured content authoring platform for pharmaceutical regulatory content management, supporting global labeling, clinical labeling, and PQ/CMC documentation processes.

glemser.com
Core offering1 text field

Glemser provides ComplianceAuthor AI, a cloud-based, GxP-compliant structured content AI platform that enables pharmaceutical and life sciences companies to author, manage, and deploy regulatory content (global labels, clinical labels, PQ/CMC documentation) across the enterprise, automatically generating submission-ready outputs in formats such as SPL, SPM, FHIR, SmPC, and QRD. The platform is complemented by on-demand label conversion services, HL7 FHIR conversion, Intelex EHSQ implementation consulting, and broader digital transformation services for regulated industries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 50% reduction in labeling timelines
+7 more records
Product overview1 text field

Glemser offers ComplianceAuthor AI®, a cloud-based structured content AI platform for pharmaceutical regulatory content management, complemented by professional services including label conversion services, HL7 FHIR conversion, Intelex EHSQ consulting, and digital transformation. ComplianceAuthor AI serves as the core product enabling AI-powered authoring, content reuse, automated compliance checks, and multi-format output generation including SPL, SPM, FHIR, SmPC, and QRD formats. The platform integrates natively with Veeva, SAP, SharePoint, Oracle, and Documentum. Supporting services include on-demand label conversion (1-2 day turnaround), HL7 FHIR conversion, Intelex implementation/validation, and digital transformation consulting for GxP, 21 CFR Part 11, and SOX environments.

Product and service6 records
1ComplianceAuthor AI®
CategoryCore SaaS platform
Description

Cloud-based, GxP-compliant AI-powered structured content authoring platform for pharmaceutical and life sciences regulatory content. Enables global teams to create, manage, and deploy structured content using component-based authoring, with automatic generation of submission-ready outputs in SPL, SPM, FHIR, SmPC, QRD, USPI, and PharmaLedger formats. Includes NLG, rule-based label generation, intelligent search, CFR Part 11 / EU Annex 11 compliance, e-Signatures, audit trails, collaborative review in Microsoft Word, and native integrations with Veeva, SAP, SharePoint, Oracle, and Documentum.

2Label Conversion Services On Demand
CategoryProfessional service
Description

On-demand outsourcing service for label conversions to SPL, SPM, ePI FHIR, and PharmaLedger formats. Customers submit files through a GxP-compliant secure portal and receive validated, submission-ready outputs in 1-2 business days. Backed by a label conversion team with 200+ years of combined experience.

3HL7 FHIR Conversion Services
CategoryProfessional service
Description

On-demand GxP-compliant service for converting product labels to HL7 FHIR format for electronic Product Information (ePI). Enables improved data exchange, accuracy, and patient safety with 1-2 business day turnaround times and the ability to begin conversion within 5 days.

4Intelex Consulting and Implementation
CategoryConsulting and implementation service
Description

Professional services for implementing, configuring, and validating Intelex Environment, Health, Safety, and Quality (EHSQ) software within regulated industries. Includes project management, GAMP 5 validation, maintenance, support, and report development for customers such as BD, Thermo Fisher Scientific, DHL, Linde, and CHR Hansen.

5Digital Transformation Services
CategoryConsulting service
Description

Consulting and professional services for modernizing legacy processes in life sciences using AI, RPA, and advanced technologies. Includes Computer System Validation (CSV) for GxP- and SOX-regulated solutions, agile process improvement, and cross-organizational transparency initiatives.

6Test Specifications for CMC (PQ/CMC Documentation)
CategoryUse-case productized offering on ComplianceAuthor AI
Description

AI-powered application of ComplianceAuthor AI for centralizing Pharmaceutical Quality / Chemistry, Manufacturing, and Controls (PQ/CMC) data and analytical methods. Manages test specifications, analytical procedures, and validation reports in a GxP-compliant environment for pharmaceutical manufacturers such as AbbVie and Incyte.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Navitas Life Sciences
Strategic tierKeyTypeStrategic or Co-development PartnerAnnounced on2023-02-06
Description

Navitas Life Sciences, a technology-backed global clinical research organization headquartered in Princeton, NJ with 1000+ employees across 5 countries, partnered with Glemser to accelerate time to market for life-saving therapies. The partnership combines Navitas' end-to-end CRO services and data science capabilities with Glemser's structured content AI for regulatory submissions. The announcement was made in February 2023.

glemser.com
Strategic tierSupportingTypeTechnology or Integration
Description

Docxonomy is an intelligent insight solution that crawls and analyzes unstructured content and structured data behind the firewall using AI and machine learning. Glemser integrates Docxonomy's capabilities for intelligent search, document classification, and Q&A within ComplianceAuthor AI, enabling users to identify relevant documents, recognize similarities, and get answers from their content repositories.

Strategic tierCoreTypeTechnology or Integration
Description

Quark provides content automation and XML publishing technology with over 40 years of experience. Glemser's ComplianceAuthor AI leverages Quark Publishing Platform and Quark XML Author to deliver an automated end-to-end solution for global labeling, IDMP, clinical labeling, and test specification processes. This is a core technology partnership underpinning the ComplianceAuthor AI platform.

Strategic tierKeyTypeImplementation/ SI/ Consulting Partner
Description

Intelex is a global leader in EHS, ESG, and Quality software. Glemser is an expert implementation and validation partner for Intelex software within regulated industries, providing consultation, configuration, validation to GAMP 5 standard, and ongoing support services for Intelex EHSQ implementations.

Strategic tierSupportingTypeTechnology or Integration
Description

Arria is the recognized global leader in Natural Language Generation (NLG), a form of generative AI that transforms structured data into natural language. Arria's software is integrated with ComplianceAuthor AI to enable deterministic natural language generation for regulatory reports and labels, combining the benefits of NLG with LLMs for mission-critical use cases in life sciences.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant cloud platform for life sciences with Veeva Vault RIM serving regulatory content management, submissions, and labeling. Direct integration partner for ComplianceAuthor AI but also the most powerful potential competitor as Vault expands into structured authoring and AI.

TypeDirect peer
Description

Life sciences technology vendor offering LifeSphere Regulatory, RIM, and safety platforms, with growing investment in AI-driven submissions and structured content. Competes directly with Glemser for pharma regulatory content and compliance budgets.

TypeDirect peer
Description

Provides the CARA structured content management and regulatory information platform purpose-built for pharma labeling, submissions, and CMC. Closest direct competitor to ComplianceAuthor AI on component-based structured content authoring.

TypeDirect peer
Description

Vendor of Ennov Doc and Ennov Regulatory suites used by life sciences for document management, SOPs, and regulatory submissions. Competes with Glemser's QC and document compliance capabilities inside regulated pharma.

TypeDirect peer
Description

Provider of the Life Sciences Suite for eCTD submissions, IDMP, and regulatory document management. Competes with Glemser on structured regulatory content and submission-ready outputs for global pharma.

TypeBroad incumbent
Description

Operates a large life sciences regulatory and clinical information portfolio including Sentri7 and pharmacovigilance tools. Competes for pharma regulatory content spend and brings incumbency advantages across enterprise pharma accounts.

TypeDirect peer
Description

Provides QMS, document control, and compliance software to life sciences and regulated manufacturers. Competes directly with Glemser's Intelex EHSQ implementation practice and broader quality/regulatory content work.

TypeBroad incumbent
Description

Global CRO and life sciences technology vendor combining regulatory services with technology platforms. Competes for enterprise pharma regulatory content, RIM, and submission services spend alongside Glemser's regulatory consulting arm.

TypeDirect peer
Description

Cloud-native QMS and EHSQ platform built on Salesforce for life sciences and manufacturing. Directly comparable to Glemser's Intelex EHSQ implementation services in regulated customers.

TypeBroad incumbent
Description

Provider of the TrackWise quality management platform now part of Honeywell's life sciences portfolio. Competes with Glemser's Intelex implementation practice across MedTech, pharma, and adjacent regulated manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers21 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Glemser

Pharmaceutical Regulatory Softwareglemser.com

Glemser is a 37-year-old private software and advisory firm that sells ComplianceAuthor AI, a GxP-compliant structured content platform, alongside label conversion, Intelex EHSQ implementation, and digital transformation services primarily to large pharmaceutical and life sciences enterprises.

What Glemser does

Glemser is a privately held U.S.-based software and advisory firm founded in 1987 by Dr. Ray Glemser and headquartered in Bethlehem, Pennsylvania, with regional operations in Ireland (EMEA) and India. The company sells ComplianceAuthor AI, a cloud-based, GxP-compliant structured content authoring platform that helps pharmaceutical and life sciences teams author, manage, and publish regulatory content (labels, SmPC, USPI, SPL, FHIR ePI, QRD, PQ/CMC documentation) using a Microsoft Word front-end and component-based content management. The platform is pre-trained on life sciences content, supports CFR Part 11 and EU Annex 11 compliance, and integrates natively with Veeva Vault RIM, SAP, SharePoint, Oracle, and Documentum.

Glemser's go-to-market combines enterprise SaaS subscriptions for ComplianceAuthor AI with several services lines that often serve as entry points: on-demand label conversion services (SPL, HL7 FHIR, PharmaLedger) with 1-2 business day turnaround, Intelex EHSQ implementation and validation, and digital transformation consulting for AI/RPA initiatives in GxP environments. The company uses an enterprise field sales motion targeting large pharmaceutical and life sciences companies, supplemented by thought leadership (DIA Global Forum, Life Sciences Review Magazine), case studies, and an ROI calculator.

The firm serves a blue-chip customer base including GSK, Pfizer, Johnson & Johnson/Janssen, Gilead Sciences, Boehringer Ingelheim, AbbVie, Takeda, Incyte, BD, Thermo Fisher, and DHL, with strategic technology partnerships spanning Quark (XML publishing), Arria (NLG), Docxonomy (intelligent search), Intelex (EHSQ), and Navitas Life Sciences (CRO services). Recognized as a 'Top Regulatory Services Company – 2024' by Life Sciences Review Magazine, Glemser positions itself as a domain-specialized alternative to horizontal content and quality management vendors for the regulated life sciences market.

Glemser firmographics

Firmographics
Name
Glemser
Legal name
Glemser, LLC
Website
https://glemser.com
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
11–50 employees
Short description
Glemser is a 37-year-old private software and advisory firm that sells ComplianceAuthor AI, a GxP-compliant structured content platform, alongside label conversion, Intelex EHSQ implementation, and digital transformation services primarily to large pharmaceutical and life sciences enterprises.
Ownership category
akta.pro rank

Glemser industry classification

Industry
Product category
Pharmaceutical Regulatory Software
NAICS
Software Publishers (51321), Computer Systems Design and Related Services (5415)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAKAK
Laboratory Quality & GLP/GCLP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAOAE
Quality Assurance, GxP Compliance & Auditing FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHDAEANAE
Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Pharmaceutical regulatory software
  • Structured content authoring
  • Label conversion services
  • Life sciences compliance
  • Regulatory content management

Where Glemser is headquartered

Location

Headquarters

HQ city
Bethlehem
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Glemser business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. ComplianceAuthor AI SaaS Platform: Cloud-based subscription access to the ComplianceAuthor AI structured content authoring platform, providing AI-powered authoring, management, and output generation for regulatory content. Sold as an enterprise license with per-seat or organizational-tier pricing.
  2. Label Conversion Services On Demand: Outsourced conversion services for SPL, HL7 FHIR ePI, and PharmaLedger label formats. Customers submit files via a secure portal and receive validated, submission-ready outputs in 1-2 business days. Revenue is generated per conversion or as an ongoing service engagement.
  3. Intelex Implementation & Consulting: Professional services for implementing and validating Intelex Environment, Health, Safety, and Quality (EHSQ) software within regulated industries. Includes project management, configuration, validation to GAMP 5 standard, and ongoing support.
  4. Digital Transformation Services: Consulting and professional services for AI, RPA, and advanced technology implementations in life sciences, including Computer System Validation (CSV) for GxP and SOX-regulated solutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Glemser product offering

Product offering

Core offering

Glemser provides ComplianceAuthor AI, a cloud-based, GxP-compliant structured content AI platform that enables pharmaceutical and life sciences companies to author, manage, and deploy regulatory content (global labels, clinical labels, PQ/CMC documentation) across the enterprise, automatically generating submission-ready outputs in formats such as SPL, SPM, FHIR, SmPC, and QRD. The platform is complemented by on-demand label conversion services, HL7 FHIR conversion, Intelex EHSQ implementation consulting, and broader digital transformation services for regulated industries.

Product overview

Glemser offers ComplianceAuthor AI®, a cloud-based structured content AI platform for pharmaceutical regulatory content management, complemented by professional services including label conversion services, HL7 FHIR conversion, Intelex EHSQ consulting, and digital transformation. ComplianceAuthor AI serves as the core product enabling AI-powered authoring, content reuse, automated compliance checks, and multi-format output generation including SPL, SPM, FHIR, SmPC, and QRD formats. The platform integrates natively with Veeva, SAP, SharePoint, Oracle, and Documentum. Supporting services include on-demand label conversion (1-2 day turnaround), HL7 FHIR conversion, Intelex implementation/validation, and digital transformation consulting for GxP, 21 CFR Part 11, and SOX environments.

Differentiator

Problem solved

Functional benefit

Brands

  • ComplianceAuthor AI: AI-powered structured content authoring platform for pharmaceutical regulatory content management, supporting global labeling, clinical labeling, and PQ/CMC documentation processes.

Products and services

  • ComplianceAuthor AI® Cloud-based, GxP-compliant AI-powered structured content authoring platform for pharmaceutical and life sciences regulatory content. Enables global teams to create, manage, and deploy structured content using component-based authoring, with automatic generation of submission-ready outputs in SPL, SPM, FHIR, SmPC, QRD, USPI, and PharmaLedger formats. Includes NLG, rule-based label generation, intelligent search, CFR Part 11 / EU Annex 11 compliance, e-Signatures, audit trails, collaborative review in Microsoft Word, and native integrations with Veeva, SAP, SharePoint, Oracle, and Documentum.
  • Label Conversion Services On Demand On-demand outsourcing service for label conversions to SPL, SPM, ePI FHIR, and PharmaLedger formats. Customers submit files through a GxP-compliant secure portal and receive validated, submission-ready outputs in 1-2 business days. Backed by a label conversion team with 200+ years of combined experience.
  • HL7 FHIR Conversion Services On-demand GxP-compliant service for converting product labels to HL7 FHIR format for electronic Product Information (ePI). Enables improved data exchange, accuracy, and patient safety with 1-2 business day turnaround times and the ability to begin conversion within 5 days.
  • Intelex Consulting and Implementation Professional services for implementing, configuring, and validating Intelex Environment, Health, Safety, and Quality (EHSQ) software within regulated industries. Includes project management, GAMP 5 validation, maintenance, support, and report development for customers such as BD, Thermo Fisher Scientific, DHL, Linde, and CHR Hansen.
  • Digital Transformation Services Consulting and professional services for modernizing legacy processes in life sciences using AI, RPA, and advanced technologies. Includes Computer System Validation (CSV) for GxP- and SOX-regulated solutions, agile process improvement, and cross-organizational transparency initiatives.
  • Test Specifications for CMC (PQ/CMC Documentation) AI-powered application of ComplianceAuthor AI for centralizing Pharmaceutical Quality / Chemistry, Manufacturing, and Controls (PQ/CMC) data and analytical methods. Manages test specifications, analytical procedures, and validation reports in a GxP-compliant environment for pharmaceutical manufacturers such as AbbVie and Incyte.

Quantifiable outcome

  • 50% reduction in labeling timelines
  • +7 more outcomes

Companies that use Glemser

Customer profile

Named customers21 records

Segments4 records

Ideal customer profiles4 records

Glemser technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability8 records

Feature10 records

Glemser partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered key, supporting and core.

  • Navitas Life ScienceskeyStrategic or Co-development Partner · 6 February 2023Navitas Life Sciences, a technology-backed global clinical research organization headquartered in Princeton, NJ with 1000+ employees across 5 countries, partnered with Glemser to accelerate time to market for life-saving therapies. The partnership combines Navitas' end-to-end CRO services and data science capabilities with Glemser's structured content AI for regulatory submissions. The announcement was made in February 2023.
  • DocxonomysupportingTechnology or IntegrationDocxonomy is an intelligent insight solution that crawls and analyzes unstructured content and structured data behind the firewall using AI and machine learning. Glemser integrates Docxonomy's capabilities for intelligent search, document classification, and Q&A within ComplianceAuthor AI, enabling users to identify relevant documents, recognize similarities, and get answers from their content repositories.
  • QuarkcoreTechnology or IntegrationQuark provides content automation and XML publishing technology with over 40 years of experience. Glemser's ComplianceAuthor AI leverages Quark Publishing Platform and Quark XML Author to deliver an automated end-to-end solution for global labeling, IDMP, clinical labeling, and test specification processes. This is a core technology partnership underpinning the ComplianceAuthor AI platform.
  • IntelexkeyImplementation/ SI/ Consulting PartnerIntelex is a global leader in EHS, ESG, and Quality software. Glemser is an expert implementation and validation partner for Intelex software within regulated industries, providing consultation, configuration, validation to GAMP 5 standard, and ongoing support services for Intelex EHSQ implementations.
  • ArriasupportingTechnology or IntegrationArria is the recognized global leader in Natural Language Generation (NLG), a form of generative AI that transforms structured data into natural language. Arria's software is integrated with ComplianceAuthor AI to enable deterministic natural language generation for regulatory reports and labels, combining the benefits of NLG with LLMs for mission-critical use cases in life sciences.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Glemser competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant cloud platform for life sciences with Veeva Vault RIM serving regulatory content management, submissions, and labeling. Direct integration partner for ComplianceAuthor AI but also the most powerful potential competitor as Vault expands into structured authoring and AI.
  • Wolters Kluwer (UpToDate / Life Sciences): Operates a large life sciences regulatory and clinical information portfolio including Sentri7 and pharmacovigilance tools. Competes for pharma regulatory content spend and brings incumbency advantages across enterprise pharma accounts.
  • IQVIA: Global CRO and life sciences technology vendor combining regulatory services with technology platforms. Competes for enterprise pharma regulatory content, RIM, and submission services spend alongside Glemser's regulatory consulting arm.
  • Sparta Systems (a Honeywell company): Provider of the TrackWise quality management platform now part of Honeywell's life sciences portfolio. Competes with Glemser's Intelex implementation practice across MedTech, pharma, and adjacent regulated manufacturers.

Direct peers

  • ArisGlobal: Life sciences technology vendor offering LifeSphere Regulatory, RIM, and safety platforms, with growing investment in AI-driven submissions and structured content. Competes directly with Glemser for pharma regulatory content and compliance budgets.
  • Generis (CARATEC/CARA): Provides the CARA structured content management and regulatory information platform purpose-built for pharma labeling, submissions, and CMC. Closest direct competitor to ComplianceAuthor AI on component-based structured content authoring.
  • Ennov: Vendor of Ennov Doc and Ennov Regulatory suites used by life sciences for document management, SOPs, and regulatory submissions. Competes with Glemser's QC and document compliance capabilities inside regulated pharma.
  • Lorenz Life Sciences: Provider of the Life Sciences Suite for eCTD submissions, IDMP, and regulatory document management. Competes with Glemser on structured regulatory content and submission-ready outputs for global pharma.
  • MasterControl: Provides QMS, document control, and compliance software to life sciences and regulated manufacturers. Competes directly with Glemser's Intelex EHSQ implementation practice and broader quality/regulatory content work.
  • ComplianceQuest: Cloud-native QMS and EHSQ platform built on Salesforce for life sciences and manufacturing. Directly comparable to Glemser's Intelex EHSQ implementation services in regulated customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Glemser social profiles

Digital presence

Glemser compliance and trust

Trust signal

Compliance4 records

Glemser financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Glemser leadership team

Management profile

Number of profiles

Profiles7 records

Glemser funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Glemser M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Glemser

What does Glemser do?

Glemser provides ComplianceAuthor AI, a cloud-based, GxP-compliant structured content AI platform that enables pharmaceutical and life sciences companies to author, manage, and deploy regulatory content (global labels, clinical labels, PQ/CMC documentation) across the enterprise, automatically generating submission-ready outputs in formats such as SPL, SPM, FHIR, SmPC, and QRD. The platform is complemented by on-demand label conversion services, HL7 FHIR conversion, Intelex EHSQ implementation consulting, and broader digital transformation services for regulated industries.

Is Glemser a public or private company?

Glemser is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Glemser founded?

Glemser was founded in 1987. It employs 11 to 50 people.

Where is Glemser based?

Glemser is headquartered in Bethlehem, United States, in the North America region.

How does Glemser make money?

Four revenue lines are on record. ComplianceAuthor AI SaaS Platform is the primary driver. The others are label Conversion Services On Demand, intelex Implementation & Consulting and digital Transformation Services.

Who are Glemser's main competitors?

Broad incumbents on record are Veeva Systems, Wolters Kluwer (UpToDate / Life Sciences), IQVIA and Sparta Systems (a Honeywell company). Direct peers are ArisGlobal, Generis (CARATEC/CARA), Ennov, Lorenz Life Sciences, MasterControl and ComplianceQuest.

Does Glemser have an API?

Yes. ComplianceAuthor AI® has the ability to interface with existing systems via application programming interface (API) configuration. Interfaces can be established to crawl and monitor data for insights and to publish approved data and documents into desired repositories. The API enables integration with RIM and document management systems.

What industry is Glemser in?

Glemser's product category is Pharmaceutical Regulatory Software. Its primary akta.pro industry code is HLAGAJAI, Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs), with a secondary code of HLAGAKAK, Laboratory Quality & GLP/GCLP Compliance. Its NAICS code is 51321 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGlemser Technologies et Arria NLG annoncent un partenariat stratégiqueArria NLG and Glemser Technologies announced a strategic partnership to integrate Arria's natural language generation technology into Glemser's services for the pharmaceutical industry. This collaboration aims to automate medical and regulatory reporting, thereby accelerating clinical trial results submission and improving operational efficiency for life sciences clients.PR NewswireGlemser Technologies e Arria NLG anunciam aliança estratégicaArria NLG has formed a strategic partnership with Glemser Technologies to enhance the ability of pharmaceutical clients to automate the writing of clinical and regulatory reports. This collaboration aims to improve efficiency and reduce costs in the drug development process, enabling faster market delivery of life-saving medications. The partnership highlights the growing importance of automation in the pharmaceutical industry.PR NewswireGlemser Technologies y Arria NLG anuncian alianza estratégicaArria NLG and Glemser Technologies announced a strategic partnership to provide natural language generation automation solutions to pharmaceutical and healthcare companies. Glemser will integrate Arria's NLG technology into its global Life Sciences Practice to automate clinical safety reports, compliance reports, and regulatory filings. The collaboration aims to reduce costs, save time, and accelerate the speed at which pharmaceutical companies can bring drugs to market by streamlining the reporting process.NewswireGlemser Technologies and Arria NLG announce strategic partnershipArria NLG and Glemser Technologies announced a strategic partnership to automate medical and regulatory report writing for pharmaceutical clients. The collaboration aims to accelerate drug development by reducing time and cost, with Glemser integrating Arria's NLG technology into its Life Sciences Practice.PR NewswireGlemser Technologies and Arria NLG announce strategic partnershipArria NLG announced a strategic partnership with Glemser Technologies on May 19, 2020, to provide Natural Language Generation solutions for pharmaceutical companies. The collaboration will automate medical and regulatory report writing, including Clinical Safety Reports and Compliance Reports. The partnership aims to enable pharma companies to reduce costs, improve accuracy, and accelerate time to market for life-saving drugs by freeing medical writers from tedious, error-prone reporting tasks.GlobeNewswireGlemser and Intelex Partner to Deliver Optimized Quality Management Solutions to Life Science MarketGlemser Technologies and Intelex Technologies announced a partnership to deliver quality management solutions to medical device and pharmaceutical manufacturers in North America. The collaboration combines Glemser's 25 years of compliance implementation experience with Intelex's cloud-based EHSQ platform, aiming to reduce customization and total cost of ownership. A live webinar on September 13, 2017 will present the solutions.Keystone EdgeFounder Profile: Ray Glemser of Glemser Technologies Corp.Ray Glemser founded Glemser Technologies Corp. in 1987, providing software and advisory services for life science companies to organize documentation for regulatory compliance. The company lost 95% of its income in 1992-1993 after IBM's repositioning and now serves clients like Pfizer and Johnson & Johnson. It is expanding its content management and quality management practices.